Flying Health’s Post

🌍 Join Our World Population Day Symposium: A Global Perspective on Non-Communicable Diseases Mark your calendars for July 11, 2024, and be part of an important dialogue at our symposium, organised by Julius Global Health (Global Health UMC Utrecht UMC Utrecht, Universiteit Utrecht), and Kenniscentrum Global Health (KCGH). This event will delve into the increasing impact of non-communicable diseases (#NCDs) on global health, especially in low-and-middle income countries (LMICs), also in light of the growing and changing population on #WorldPopulationDay. 🔹 Event Details: Venue: Academiegebouw, Universiteit Utrecht Time: 19:00 - 22:00 🔹 Keynote Speakers: Prof. Vilma Irazola: Director of the Department of Chronic Diseases at the Institute for Clinical Effectiveness and Health Policy, Argentina. An expert in public health and epidemiology, focusing on chronic disease prevention and management. Prof. Elvin Geng: Professor of Medicine at Washington University in St. Louis. A pioneer in implementation science, Dr. Geng’s work enhances health interventions worldwide. 🔹 Panel Discussion: Join our keynote speakers along with Arti Singh, MD, PhD, Senior Lecturer at the School of Public Health at KNUST, Ghana, and Prof. Oscar H. Franco from Julius Global Health for an engaging panel discussion involving the audience. 🍸 Networking: The evening will conclude with a networking session over drinks, providing a great opportunity to connect with peers and thought leaders in the field. 🎟️ Admission: General Entrance: €15 Reduced Fee: €5 (Students/LMICs/NVTG Members) 💡 This symposium offers a crucial platform to explore the complexities of NCDs and their disproportionate effects on LMICs. Don’t miss the chance to gain insights from global experts and expand your professional network. NVTG #Accreditation is pending. 🔗 Ready to join us? Register now by clicking the 'inschrijven' button below all information: https://lnkd.in/edVcCJQP #GlobalHealth #NCDs #WorldPopulationDay #PublicHealth #UMCUtrecht #KCGH

The Need for International Cooperation During Covid-19 Pandemic: With the spread of the novel coronavirus and the increasing number of cases and deaths, almost no community or country can resist this rapidly evolving threat. Dramatically limit the spread of COVID-19, take care of the sick, prevent deaths, reduce social and economic damage, and meet basic human needs. All classes of our society are taking urgent actions. Uncertainty is imminent, and we need to do a lot of things. Covid-19 Has Risen the Need for Global Coordination of Healthcare A collaborative, science-based coordinated and transparent global response is required to contain and respond to this pandemic. All countries are concerned about the severe threats and risks faced, especially developing countries and the underdeveloped, conflict-affected countries, and post-conflict countries with insufficient medical systems. The urgency of international cooperation must be emphasized in several ways: International communication A fast, accurate and transparent international exchange on the epidemics of this new viral disease is needed. It includes the duration of incubation, the mode of transmission, and the lethality and effectiveness of the various intervention methods. Sharing of information Coordination activities to share real-time detailed scientific information on viruses, the pathophysiology of the diseases, cause and the regulation of their origin, human immune responses, heredity, and mutations, and to improve knowledge in all these areas. Countries must share information on the research and development of medical products used to treat diseases and conduct joint research. Availability of standard products To accelerate the availability of safe personal protective equipment, diagnostic test equipment and medical functions, mutual trust, coordination between regulatory and manufacturing processes is required. Coordinated analysis and public awareness Work together to conduct a quick but evidence-based analysis of new issues or precise planning and policy issues that may arise with the global epidemic’s development. Coordinate and develop authentic guidelines, communications, and information for the public and decision-makers in rapidly changing conditions.   How will respective policies change the national healthcare systems? For the first time in history, the health crisis shut down the entire world economy and harshly proved that health and economy were inseparable. On a global scale, our healthcare system is not designed to address this crisis. It is an unpredictable and large-scale health challenge that requires an urgent mobilization of resources and affects the entire population. Therefore, it is not important to discuss the functionality and efficiency of these systems. In many respects, the pandemic is the opposite of what the medical system… #healthcarenews #DoctorsBusinessNetwork #medicalnews

🎉Congratulations to Gisela Robles Aguilar, Lucien Swetschinski, Nicole Weaver, Mohsen Naghavi and the entire AMR collaboration on the publication of their groundbreaking study on Antimicrobial Resistance (AMR) in the WHO Region of the Americas!🌎 🔍Their comprehensive assessment estimated the deaths and disability-adjusted life-years (DALYs) attributable to and associated with AMR across 23 bacterial pathogens and 88 pathogen-drug combinations. 📊Findings reveal an estimated 569,000 deaths associated with bacterial AMR and 141,000 deaths attributable to bacterial AMR in the region in 2019, highlighting the substantial health threat AMR represents in the Americas. 🙌This monumental achievement is a crucial step towards understanding and tackling this significant global health threat. It provides essential evidence that can guide mitigation efforts, inform decisions regarding funding and resource allocation, and pave the way for multisectoral and joint cooperative efforts among countries. 💡A big shoutout to the Bill & Melinda Gates Foundation, Wellcome Trust, and the Department of Health and Social Care using UK aid funding managed by the Fleming Fund for funding this important work! Here's the citation for those interested in delving deeper into the details: Aguilar, G.R., Swetschinski, L.R., Weaver, N.D., et al. (2023). The burden of bacterial antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis. The Lancet Regional Health – Americas, 24: 100561. doi: 10.1016/j.lana.2023.100561. 📝 #AntimicrobialResistance #GlobalHealth #PublicHealth #Healthcare #Research #Innovation It is also the top read paper today so extra kudos to all those involved - https://lnkd.in/gzbtZixT

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐄𝐒𝐂𝐌𝐈𝐃 𝐆𝐥𝐨𝐛𝐚𝐥 2024: I had a fantastic time this week attending ESCMID Global 2024 in one of my favourite cities, Barcelona! I noticed a real emphasis on Sepsis and AMR—two areas that saw significant scientific advancement. Here are some of my key takeaways. 𝐄𝐧𝐡𝐚𝐧𝐜𝐞𝐝 𝐔𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝𝐢𝐧𝐠 𝐨𝐟 𝐒𝐞𝐩𝐬𝐢𝐬 𝐌𝐞𝐜𝐡𝐚𝐧𝐢𝐬𝐦𝐬: Researchers presented new findings on the pathophysiology of Sepsis, offering deeper insights into its complex biological processes. This enhanced understanding paves the way for more effective treatments and protocols. 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐬 𝐢𝐧 𝐂𝐨𝐦𝐛𝐚𝐭𝐢𝐧𝐠 𝐀𝐌𝐑: The conference highlighted innovative strategies to tackle AMR, which is a growing global threat complicating the treatment of infections, including Sepsis. Breakthroughs in new antimicrobial agents and stewardship programs underscore the urgent need for solutions that can outpace the rapid evolution of resistant bacteria. 𝐆𝐥𝐨𝐛𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐈𝐦𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬: Discussions underscored the importance of global co-operation in addressing these diseases, which remain among the top health challenges worldwide. The focus was on integrating efforts across countries and disciplines to improve patient outcomes and reduce disease transmission. 𝐏𝐮𝐛𝐥𝐢𝐜 𝐇𝐞𝐚𝐥𝐭𝐡 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬:  Significant emphasis was placed on public health strategies and policies that can help prevent and manage outbreaks. Effective surveillance systems and community engagement are critical in combating the spread of these infections. 𝐅𝐮𝐭𝐮𝐫𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐃𝐢𝐫𝐞𝐜𝐭𝐢𝐨𝐧𝐬: The conference not only addressed current challenges but also set the stage for future research, stressing the need for ongoing innovation and collaboration in the fight against infectious diseases. 𝐋𝐞𝐯𝐞𝐫𝐚𝐠𝐢𝐧𝐠 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭𝐢𝐧𝐠 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐟𝐫𝐨𝐦 𝐄𝐒𝐂𝐌𝐈𝐃 2024: During the conference, discussions revealed significant digital marketing trends, particularly the strategic use of Key Opinion Leaders (KOLs) in engaging target audiences. By partnering with KOLs who are the experts in infectious diseases, brands can enhance credibility and deepen audience engagement. This approach mirrors the importance of authoritative voices in both medical and marketing fields, highlighting a synergy that can significantly amplify message reach and impact in health-related communications.

5 identified priorities, 18 objectives, 50 measures and 152 concrete proposals for action. These were translated into the French #endometriosis action plan for the period 2022 - 2025. In March 2021, then French Minister of Solidarity and Health (Le ministre des Solidarités et de la Santé), Olivier Véran, launched work on a national strategy to combat endometriosis, involving multiple ministries. The purpose of the action plan is to; - Fully recognize the consequences of endometriosis - Address the needs of women with endometriosis - Provide better support for women suffering from it - Make rapid progress in knowledge about the disease, its detection and diagnosis, and its treatment. The strategy emphasizes the need for a holistic, multidisciplinary approach to this societal disease, which is a public health problem. It calls on all those involved in the management of endometriosis to mobilize, to be innovative and creative, and to use all the means at their disposal to further the fight against this disease.   Several relevant stakeholders - patient organizations, healthcare professionals and researchers have been involved in the development of the strategy. To this end, five working groups representing these stakeholders have been established, organized as follows: - Working Group 1: Education, Communication and Awareness - Working Group 2: Education of healthcare professionals - Working Group 3: Detection and Diagnosis - Workgroup 4: Personalized and comprehensive care pathways (Shoutout to FEMaLe project adviser Horace Roman) - Workgroup 5: Research, innovation and epidemiology (Shoutout to FEMaLe partner Nicolas Bourdel from SURGAR and adviser Marina Kvaskoff) (PDF) French Endometriosis Action plan https://lnkd.in/e-vbeck6 -- #female #letsmakelifebetter #1in10  #fempowerment #findingendometriosis #femtech #endometriosisawareness #womenshealthmatters #diagnosis #actionplan Andrew Horne Philippa Saunders Lone Hummelshoj Dorte Rytter Mette Nyegaard Krina Zondervan Liv Juul Nielsen Attila Bokor Camilla Fabricius Gabriella Márki Nilufer Rahmioglu Dmitrijs Bļizņuks Sebastiaan Meijer Jayanth Raghothama Bruno Sales da Silva Gert L. Møller Simon Beaulah Steve Gardner Ole Goethe Nemanja Todić Adrienn Salamon Aarhus Universitet Ulrik Bak Kirk Ole Bækgaard Nielsen Correlate Engin Oral Francesco Mureddu Dr. Mathew Leonardi Deborah Bush MNZM QSM Emmanuel Macron Association EndoFrance Louise Dreisig

The Pandemic Preparedness Engaging Primary Care and Emergency Departments (PREPARED) network, led by Andrew Pinto, scientist and family physician at Unity Health Toronto, is a national pandemic preparedness system that will improve Canada’s capacity to identify and track new pathogens, monitor disease spread and speed up the research and development of diagnostic tests, vaccines and therapeutics. PREPARED aims to build a coordinated ecosystem that can swiftly respond to new viruses or pathogens by connecting primary care clinics and emergency departments across Canada with research institutions and industry partners, including:  Alliance for Healthier Communities, Aumintec Inc., BlueDot, CASTL - Canadian Alliance for Skills and Training in Life Sciences , Citest Diagnostics Inc., DNAstack, Edesa Biotech, Inc., Genomadix, INSPIRE Primary Health Care Research Network, MAP Centre for Urban Health Solutions, McGill Primary Care Practice-Based Research Network, McGill University, McMaster University, Mediphage Bioceuticals, Memorial University, Newfoundland and Labrador, Metagenom Bio Life Science, Moderna, NL Health Services, Norgen Biotek, North York General Hospital, Northern Alberta Primary Care Research Network, NOSM University | Université EMNO, Ontario Ministry of Health, Public Health Agency of Canada | Agence de la santé publique du Canada, Queen's University, RI-MUHC | Research Institute of the MUHC | #rimuhc#rimuhc, RRAPPL Réseau de Recherche Axé sur les Pratiques de Première Ligne, Simon Fraser University, Tenacity Genomic Solutions, Université de Montréal, Université de Sherbrooke, Université Laval, University Health Network, University of Alberta, The University of British Columbia, University of Calgary, University of Manitoba, University of Ottawa, University of St Andrews, University of Toronto, Upstream Lab, VITAM - Centre de recherche en santé durable, Western University Learn more about how this program will help prepare Canada for the next health emergency here: https://lnkd.in/gHdsMHx2 This program is part of foundational investments made by the Government of Canada to continue growing a strong, competitive biomanufacturing and life sciences sector. TIPS-SPIIE, Innovation, Science and Economic Development Canada

Why should we choose an efficient and safe prevention of infections? Modifying the protein sequences by chemicals is the primary cause of cell pathology. The oxidative stress in the life span is a "natural" cause of aging. However, acute oxidative stress in every infection leads to rapid protein modifications. Everybody experiences the feeling very severely after 2-3 days from the start of infection. Anti-pain drugs are advised, leading to the alleviation of symptoms but accelerating the accumulation of modified proteins. Patients with weak immunity develop cardiovascular or kidney problems after infections because the modified proteins permanently activate caspases and destroy mitochondria. People are not safe, and the specialists from WHO project Disease X and probably also introduce a vaccine like the COVID pandemic. https://lnkd.in/dJnYQbYs The dangerous strains are prepared and can escape YouTube·Dr. John Campbell·11 Jan 2024 The quick propagation of infection leads to political pressure to accept an ad hoc proposition like mRNA vaccines anti-COVID. The regulatory agency probably disposed of the receipt of the vaccine, but they still do not accept that accumulation of the modified sequences leads to cell pathology. The mRNA vaccines produced "frameshifted polypeptides that were found to elicit an off-target cellular immune response following vaccination of mice and humans with modified mRNA." https://lnkd.in/dCDwpMGu The peptides are modified in the condition of oxidative stress induced by the vaccination, leading to new protein-protein interactions and cell pathologies as the cancer incidence observed currently even in young people. https://lnkd.in/dTVXVMw9 Modifying the protein interactions due to vaccination is the key to the vaccine's safety, and more attention should be paid to what it proposes as the vaccine antigens. https://lnkd.in/dUC5d_Qn    MEMS is the ideal solution to boost host immunity by safely removing the modified sequences from the membranes and restoring efficient immunity. We do not need to add a modified protein to the cell, but removing the modified proteins restores the cell regeneration and protein regulation, healing the host.